Immunotherapy for non-small cell lung cancer

被引：11
|
作者：
Vafadar, Sam [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol, Tampa, FL 33612 USA
来源：
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2019年 / 32卷 / 09期
关键词：
non-small cell lung cancer; immunotherapy; nivolumab; pembrolizumab; atezolizumab; durvalumab; ADVERSE EVENTS; OPEN-LABEL; PEMBROLIZUMAB; NIVOLUMAB; DOCETAXEL;
D O I：
10.1097/01.JAA.0000569792.99069.e6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Immunotherapy is a new genre of treatment for patients with advanced cancer. Initially approved for use in metastatic melanoma, immunotherapy has found a significant place in treating non-small cell lung cancer (NSCLC). Clinical trials using several combinations of immunotherapy are underway to help to determine the best treatment for specific patient groups. This article reviews approved uses of immunotherapy for NSCLC, immune-related toxicities, and explores the future direction of this treatment.
引用
下载
收藏
页码：37 / 42
页数：6
相关论文
共 50 条
  • [21] Perioperative Immunotherapy in Non-Small Cell Lung Cancer
    O'Brien, Jenny
    Bodor, J. Nicholas
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (12) : 1790 - 1801
  • [22] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [23] Adjuvant immunotherapy for non-small cell lung cancer
    Tucker, Zachary C. G.
    Laguna, Benjamin A.
    Moon, Edmund
    Singhal, Sunil
    CANCER TREATMENT REVIEWS, 2012, 38 (06) : 650 - 661
  • [24] Dendritic cell immunotherapy in non-small cell lung cancer
    Choi, Y.
    Chung, J.
    Shin, H.
    Cho, G.
    Sohn, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer
    Bar, Jair
    Ofek, Efrat
    Barshack, Iris
    Gottfried, Teodor
    Zadok, Oranit
    Kamer, Iris
    Urban, Damien
    Perelman, Marina
    Onn, Amir
    LUNG CANCER, 2019, 138 : 109 - 115
  • [26] ACTIVE IMMUNOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER
    Neninger, Elia
    Camilo Rodriguez, Pedro
    Crombet, Tania
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S194 - S194
  • [27] Chemotherapy: A partnership with immunotherapy in non-small cell lung cancer
    Mendes, Ana Sofia
    Romao, Raquel
    Febra, Joana
    Azevedo, Sergio Xavier
    Fidalgo, Paula
    Araujo, Antonio
    THORACIC CANCER, 2023, 14 (05) : 437 - 441
  • [28] Understanding the Rationale for Immunotherapy in Non-Small Cell Lung Cancer
    Pennell, Nathan A.
    SEMINARS IN ONCOLOGY, 2015, 42 (05) : S3 - S10
  • [29] Personalized immunotherapy for advanced non-small cell lung cancer
    Herbst, Roy S.
    ANNALS OF ONCOLOGY, 2015, 26 : 16 - 16
  • [30] Immunotherapy as a targeted therapy in non-small cell lung cancer
    Rocco, Danilo
    Della Gravara, Luigi
    Avellino, Aniello
    Montesarchio, Vincenzo
    Battiloro, Ciro
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S70 - S75
12345